Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease
International Journal of Molecular Sciences · 13.02.2023 · 24 (4) · 3735
DOI: 10.3390/ijms24043735 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.02.2023. Verfasst von Marija Dukić und 17 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Medical Center Bežanijska Kosa, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, Fatty Liver, Alcoholic, Microbiota. Die Arbeit wurde bisher 158-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Alcoholic liver disease (ALD) is a consequence of excessive alcohol use. According to many studies, alcohol represents a significant socioeconomic and health risk factor in today’s population. According to data from the World Health Organization, there are about 75 million people who have alcohol disorders, and it is well known that its use leads to serious health problems. ALD is a multimodality spectrum that includes alcoholic fatty liver disease (AFL) and alcoholic steatohepatitis (ASH), consequently leading to liver fibrosis and cirrhosis. In addition, the rapid progression of alcoholic liver disease can lead to alcoholic hepatitis (AH). Alcohol metabolism produces toxic metabolites that lead to tissue and organ damage through an inflammatory cascade that includes numerous cytokines, chemokines, and reactive oxygen species (ROS). In the process of inflammation, mediators are cells of the immune system, but also resident cells of the liver, such as hepatocytes, hepatic stellate cells, and Kupffer cells. These cells are activated by exogenous and endogenous antigens, which are called pathogen and damage-associated molecular patterns (PAMPs, DAMPs). Both are recognized by Toll-like receptors (TLRs), which activation triggers the inflammatory pathways. It has been proven that intestinal dysbiosis and disturbed integrity of the intestinal barrier perform a role in the promotion of inflammatory liver damage. These phenomena are also found in chronic excessive use of alcohol. The intestinal microbiota has an important role in maintaining the homeostasis of the organism, and its role in the treatment of ALD has been widely investigated. Prebiotics, probiotics, postbiotics, and symbiotics represent therapeutic interventions that can have a significant effect on the prevention and treatment of ALD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Hospital Medical Center Bežanijska Kosa, 11000 Belgrade, Serbia.
- Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Tijana Radonjić, Zoran Todorović, Olga Mandić, Višeslav Popadić, Slobodan Klašnja, Marija Branković
Zitieren
APA
Dukić, M., Radonjić, T., Jovanović, I., Zdravković, M., Todorović, Z., Kraišnik, N., Aranđelović, B., Mandić, O., Popadić, V., Nikolić, N., Klašnja, S., Manojlović, A., Divac, A., Gačić, J., Brajković, M., Oprić, S., Popović, M., & Branković, M. (2023). Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease. International Journal of Molecular Sciences, 24(4), 3735. https://doi.org/10.3390/ijms24043735
Vancouver
Dukić M, Radonjić T, Jovanović I, Zdravković M, Todorović Z, Kraišnik N, et al. Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease. International Journal of Molecular Sciences. 2023;24(4):3735. doi:10.3390/ijms24043735
BibTeX
@article{Duki2023,
author = {Dukić, Marija and Radonjić, Tijana and Jovanović, Igor and Zdravković, Marija and Todorović, Zoran and Kraišnik, Nemanja and Aranđelović, Bojana and Mandić, Olga and Popadić, Višeslav and Nikolić, Novica and Klašnja, Slobodan and Manojlović, Andrea and Divac, Anica and Gačić, Jasna and Brajković, Milica and Oprić, Svetlana and Popović, Maja and Branković, Marija},
title = {Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3735},
doi = {10.3390/ijms24043735}
}
EUVIMED